BioNTech's Q1 Loss Widens, Revenue Falls; Maintains 2025 Revenue Guidance

MT Newswires Live

05/05

BioNTech SE reported a Q1 loss Monday of 1.73 euros ($1.96) per diluted share, wider than a loss of 1.31 euros a year earlier.

Analysts polled by FactSet expected a loss of 1.84 euros.

Revenue for the quarter ended March 31 was 182.8 million euros compared with 187.6 million euros a year earlier.

Analysts surveyed by FactSet expected 198.8 million euros.

The company maintained its 2025 revenue guidance of 1.70 billion euros to 2.20 billion euros. Analysts polled by FactSet expect 2.05 billion euros.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2533588567"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2533588567\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2533588567?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-05 19:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2533588567","market":"us","top_or_hot":-1,"title":"BioNTech's Q1 Loss Widens, Revenue Falls; Maintains 2025 Revenue Guidance","media":"MT Newswires Live","content":"<html><head></head><body><p><a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> reported a Q1 loss Monday of 1.73 euros ($1.96) per diluted share, wider than a loss of 1.31 euros a year earlier.</p><p>Analysts polled by FactSet expected a loss of 1.84 euros.</p><p>Revenue for the quarter ended March 31 was 182.8 million euros compared with 187.6 million euros a year earlier.</p><p>Analysts surveyed by FactSet expected 198.8 million euros.</p><p>The company maintained its 2025 revenue guidance of 1.70 billion euros to 2.20 billion euros. Analysts polled by FactSet expect 2.05 billion euros.</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech's Q1 Loss Widens, Revenue Falls; Maintains 2025 Revenue Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech's Q1 Loss Widens, Revenue Falls; Maintains 2025 Revenue Guidance\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-05-05 19:15</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><head></head><body><p><a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> reported a Q1 loss Monday of 1.73 euros ($1.96) per diluted share, wider than a loss of 1.31 euros a year earlier.</p><p>Analysts polled by FactSet expected a loss of 1.84 euros.</p><p>Revenue for the quarter ended March 31 was 182.8 million euros compared with 187.6 million euros a year earlier.</p><p>Analysts surveyed by FactSet expected 198.8 million euros.</p><p>The company maintained its 2025 revenue guidance of 1.70 billion euros to 2.20 billion euros. Analysts polled by FactSet expect 2.05 billion euros.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BNTX","symbol_name":"BioNTech SE","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2533588567","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2533588567","pubTimestamp":1746443739,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"BioNTech SE  reported a Q1 loss Monday of 1.73 euros  per diluted share, wider than a loss of 1.31 euros a year earlier.Analysts polled by FactSet expected a loss of 1.84 euros.Revenue for the quarter ended March 31 was 182.8 million euros compared with 187.6 million euros a year earlier.Analysts surveyed by FactSet expected 198.8 million euros.The company maintained its 2025 revenue guidance of 1.70 billion euros to 2.20 billion euros. Analysts polled by FactSet expect 2.05 billion euros.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"BNTX":"BioNTech SE"},"translate_title":"BioNTech第一季度亏损扩大，收入下降；维持2025年收入指引","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BNTX":0.9},"content_text":"BioNTech SE reported a Q1 loss Monday of 1.73 euros ($1.96) per diluted share, wider than a loss of 1.31 euros a year earlier.Analysts polled by FactSet expected a loss of 1.84 euros.Revenue for the quarter ended March 31 was 182.8 million euros compared with 187.6 million euros a year earlier.Analysts surveyed by FactSet expected 198.8 million euros.The company maintained its 2025 revenue guidance of 1.70 billion euros to 2.20 billion euros. Analysts polled by FactSet expect 2.05 billion euros.","kind":"highlight","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}